Ascentage Pharma Group International (OTCMKTS:ASPHF) Short Interest Up 69.0% in October

Ascentage Pharma Group International (OTCMKTS:ASPHF) was the target of a large increase in short interest in October. As of October 31st, there was short interest totalling 607,700 shares, an increase of 69.0% from the October 15th total of 359,500 shares. Based on an average daily volume of 270,200 shares, the days-to-cover ratio is presently 2.2 days.

Ascentage Pharma Group International Stock Performance

OTCMKTS:ASPHF remained flat at $6.45 on Friday. Ascentage Pharma Group International has a 12 month low of $6.45 and a 12 month high of $6.45. The business has a 50 day moving average of $4.19 and a 200 day moving average of $3.20.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International, a clinical-stage biotechnology company, engages in developing therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in the United States and Mainland China. Its primary product HQP1351, a BCR-ABL inhibitor targeting BCR-ABL mutants, including those with the T315I mutation.